JPS6422A - Prophylactic and remedy for hypocalcemia and bone catabolism - Google Patents
Prophylactic and remedy for hypocalcemia and bone catabolismInfo
- Publication number
- JPS6422A JPS6422A JP62085436A JP8543687A JPS6422A JP S6422 A JPS6422 A JP S6422A JP 62085436 A JP62085436 A JP 62085436A JP 8543687 A JP8543687 A JP 8543687A JP S6422 A JPS6422 A JP S6422A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- preparation
- remedy
- prophylactic
- hypocalcemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: To obtain a prophylactic preparation or a remedy for diseases caused by insufficiency of calcium in living body tissues, by using calcium hexosephosphate as an active ingredient, thus enabling the drug to be administered for a long period of time without side-actions.
CONSTITUTION: Calcium hexose-phosphate, preferably calcium glucose-phosphate is used, as an active ingredient, to give the subject preparation. The preparation has good absorption properties, increases the calcium concentration in blood and strengthens bone strength. The dose of the preparation is 1W50g, preferably 10W30g/day/adult.
COPYRIGHT: (C)1989,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62-85436A JPH0122A (en) | 1987-02-12 | 1987-04-07 | Preventive/therapeutic agents for hypocalcemia and bone metabolic disorders |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62-30513 | 1987-02-12 | ||
JP3051387 | 1987-02-12 | ||
JP62-85436A JPH0122A (en) | 1987-02-12 | 1987-04-07 | Preventive/therapeutic agents for hypocalcemia and bone metabolic disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
JPS6422A true JPS6422A (en) | 1989-01-05 |
JPH0122A JPH0122A (en) | 1989-01-05 |
JPH0541606B2 JPH0541606B2 (en) | 1993-06-24 |
Family
ID=
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1477171A1 (en) | 2003-05-16 | 2004-11-17 | Kao Corporation | Intestinal mineral absorption capacity improver |
JP2005002090A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Alternative agent for vitamin d-like activity |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1477171A1 (en) | 2003-05-16 | 2004-11-17 | Kao Corporation | Intestinal mineral absorption capacity improver |
JP2005002091A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Intestinal mineral absorption capacity improver |
JP2005002090A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Alternative agent for vitamin d-like activity |
JP4634027B2 (en) * | 2003-05-16 | 2011-02-16 | 花王株式会社 | Vitamin D-like active substitute |
Also Published As
Publication number | Publication date |
---|---|
JPH0541606B2 (en) | 1993-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2139892B (en) | Solid pharmaceutical preparation containing nifedipine | |
ID24901A (en) | METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED | |
DK339289D0 (en) | PHARMACEUTICAL PREPARATION | |
Minot et al. | Use of guanidine hydrochloride in treatment of myasthenia gravis | |
EP0388799A3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
ATE147623T1 (en) | MEDICINAL PREPARATION FOR PRODUCING A STABILIZED POWDER CONTAINING A COMBINATION OF ACETYLSALICYLIC ACID AND METOCLOPRAMIDE AS THE ACTIVE INGREDIENTS | |
JPS6422A (en) | Prophylactic and remedy for hypocalcemia and bone catabolism | |
EP0310126A3 (en) | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | |
KR100271087B1 (en) | Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia | |
KR900007434A (en) | Therapeutics with cystatin as active ingredients | |
TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
Blanchet et al. | Effects of methyl methacrylate monomer vapors on respiration and circulation in unanesthetized rats | |
Laszlo et al. | Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate | |
GR3000751T3 (en) | Tpa-containing medical composition and use thereof | |
KR880002521A (en) | Pharmaceutical formulation | |
ATE66375T1 (en) | USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES. | |
JPS643123A (en) | Remedy for skin inflammation | |
RU92001958A (en) | METHOD OF OBTAINING FIBRINE PASTE | |
JPS5735511A (en) | Dermatic medicine for external application | |
JPS6442423A (en) | Remedy containing propaphenone antipode | |
JPS6463521A (en) | Trapidyl-containing drug composition, manufacture and related therapeutical use | |
HK63592A (en) | Medical preparation comprising aspoxicillin,a method for its preparation,and the use of such a preparation for the manufacture of a medicament | |
RU2119342C1 (en) | Herbs species n 2 with common restorative effect | |
NO952426L (en) | New drug containing 3,7-diazabicyclo [3.3.1] Nonan compounds | |
Kustos et al. | Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. II. Effects of the type and localisation of fracture on the urinary excretion of hydroxyproline and glycosaminoglycans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070624 Year of fee payment: 14 |